Genesis Healthcare, Inc. Stock Other OTC
Equities
GEN
US37185X1063
Healthcare Facilities & Services
Financials (USD)
Sales 2021 * | 3.46B | Sales 2022 * | - | Capitalization | 134K |
---|---|---|---|---|---|
Net income 2021 * | -22M | Net income 2022 * | - | EV / Sales 2021 * | 0.95 x |
Net Debt 2021 * | 3.28B | Net cash position 2022 * | - | EV / Sales 2022 * | - |
P/E ratio 2021 * |
-0.01
x | P/E ratio 2022 * |
-
| Employees | - |
Yield 2021 * |
-
| Yield 2022 * |
-
| Free-Float | 46.99% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | - | 21-01-31 | |
Public Communications Contact | - | - | |
Susan Overton
LAW | General Counsel | - | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 15-02-01 | |
John Randazzo
BRD | Director/Board Member | 69 | 21-03-01 |
Chairman | 79 | 21-03-01 |
1st Jan change | Capi. | |
---|---|---|
-14.92% | 84.68B | |
+13.30% | 81.12B | |
+10.92% | 29.4B | |
-12.71% | 16.73B | |
-3.06% | 16.36B | |
-2.63% | 14.92B | |
-31.75% | 11.77B | |
-1.42% | 11.72B | |
+27.44% | 11.71B |